Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Edward Ashwood to Down Syndrome

This is a "connection" page, showing publications Edward Ashwood has written about Down Syndrome.

 
Connection Strength
 
 
 
0.607
 
  1. Lepage N, Wyatt P, Ashwood ER, Best RG, Long T, Palomaki GE. Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020. J Med Screen. 2021 12; 28(4):405-410.
    View in: PubMed
    Score: 0.134
  2. Palomaki GE, Wyatt P, Best RG, Lepage N, Ashwood ER, Souers RJ, Thorson JA. Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784.
    View in: PubMed
    Score: 0.121
  3. Walker BS, Jackson BR, LaGrave D, Ashwood ER, Schmidt RL. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat Diagn. 2015 May; 35(5):440-6.
    View in: PubMed
    Score: 0.087
  4. Walker B, Ashwood ER, Jackson BR, Lagrave D. A tradeoff analysis of risk cutoffs for the quadruple serum screen for Down syndrome. Prenat Diagn. 2013 Dec; 33(12):1201-6.
    View in: PubMed
    Score: 0.078
  5. Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. Screening for down syndrome in the United States: results of surveys in 2011 and 2012. Arch Pathol Lab Med. 2013 Jul; 137(7):921-6.
    View in: PubMed
    Score: 0.077
  6. Ashwood ER, Cheng E, Luthy DA. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs. Am J Med Genet. 1987 Mar; 26(3):531-9.
    View in: PubMed
    Score: 0.049
  7. Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med. 2004 Apr; 128(4):415-20.
    View in: PubMed
    Score: 0.040
  8. Ashwood ER. Evaluating health and maturation of the unborn: the role of the clinical laboratory. Clin Chem. 1992 Aug; 38(8B Pt 2):1523-9.
    View in: PubMed
    Score: 0.018
  9. Lenke RR, Ashwood ER, Cyr DR, Gravett M, Smith JR, Stenchever MA. Genetic amniocentesis: significance of intraamniotic bleeding and placental location. Obstet Gynecol. 1985 Jun; 65(6):798-801.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)